Management of Colitis in the Inpatient Setting
For patients with acute severe ulcerative colitis requiring hospitalization, intravenous corticosteroids (methylprednisolone 40-60 mg daily or hydrocortisone 100 mg four times daily) are the first-line treatment. 1, 2
Initial Assessment and Management
Diagnostic Evaluation
- Perform urgent inpatient assessment including:
First-Line Treatment
- Intravenous corticosteroids:
Supportive Care
- IV fluid and electrolyte replacement (potassium supplementation ≥60 mmol/day)
- Subcutaneous low-molecular-weight heparin for thromboprophylaxis
- Nutritional support for malnourished patients (enteral preferred over parenteral)
- Blood transfusion to maintain hemoglobin above 8-10 g/dl 2
Monitoring Response
Assessment of Response
- Assess response to IV corticosteroids by day 3 2
- Poor response indicators include:
- Persistent symptoms
- Elevated inflammatory markers
8 stools per day or 3-8 stools with CRP >45 mg/L 2
- Daily monitoring of:
- Vital signs
- Stool frequency
- Laboratory parameters
- Abdominal radiography if colonic dilatation is present (transverse colon >5.5 cm) 2
Rescue Therapy for Non-Responders
For Patients Not Responding to IV Steroids by Day 3:
Considerations for Rescue Therapy Selection:
- Infliximab advantages:
- Better short-term safety profile
- Option for maintenance treatment
- Preferred in patients already exposed to immunosuppressives 3
- Cyclosporine advantages:
Surgical Management
Indications for Colectomy:
- No improvement after 4-7 days of rescue therapy
- Failure to respond to medical therapy within 48-72 hours
- Toxic megacolon with clinical deterioration
- Free perforation
- Life-threatening hemorrhage 2
Surgical Consultation:
- Early involvement of colorectal surgeons is essential
- Delayed surgical consultation can lead to poor outcomes 2
Discharge Planning and Follow-up
Discharge Criteria:
- Resolution of rectal bleeding (Mayo subscore 0-1)
- Stool frequency returned to baseline frequency and form (Mayo subscore 0-1)
- Stability for 24 hours before discharge 4
Discharge Medications:
- Appropriate to discharge on 40 mg prednisone with tapering over 6-8 weeks 1, 4
- Consider initiating maintenance therapy:
- For anti-TNF-naïve patients: anti-TNF therapy
- For anti-TNF-exposed patients: vedolizumab or ustekinumab 4
Follow-up:
- Clinical follow-up within 2 weeks
- Lower endoscopy within 4-6 months after discharge 4
Common Pitfalls to Avoid
- Delaying assessment of response to IV steroids beyond day 3
- Prolonging IV steroid use beyond 7-10 days without considering alternatives
- Failing to involve colorectal surgeons early in management
- Inadequate thromboprophylaxis
- Using routine adjunctive antibiotics unless specific infection is suspected 2
- Prolonging treatment with high-dose oral corticosteroids, which has diminishing chance of achieving remission and increases risk of complications 1
Maintenance Therapy After Acute Episode
For patients who respond to initial treatment, maintenance therapy should be initiated to prevent relapse: